![]() Santhera Pharmaceuticals Holding Santhera Pharmaceuticals Holding is a specialty pharmaceutical company. | ![]() Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ![]() Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | ![]() Hutchison China Meditech Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products. | ![]() Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine. | |
Founding Date | Founding Date 2004 | Founding Date 1996 | Founding Date 1849 | Founding Date 2000 | Founding Date 2010 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Pratteln, CH HQ Burlington, US | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Shanghai, CN HQ Beijing, CN Jiangsu, CN Shanghai, CN Shanghai, CN Hong Kong, HK Hong Kong, HK see more | |
Employees | Employees 5119% increase | Employees 75,883 | Employees 81,0008% decrease | Employees 1,811 | Employees 5,8004% increase |
Valuation ($) | Valuation ($) 268.6 m | Valuation ($) N/A | Valuation ($) 163.9 b | Valuation ($) 3.6 b | Valuation ($) 21.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) CHF77.2m (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) $548.5m (FY, 2025) | Revenue (est.) $1.9b (FY, 2025) |
Cost of goods | Cost of goods CHF56.3m (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods $16.1b (FY, 2025) | Cost of goods $324.4m (FY, 2025) | Cost of goods $868m (FY, 2025) |
Gross profit | Gross profit CHF21.1m (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit $46.5b (FY, 2025) | Gross profit $224.2m (FY, 2025) | Gross profit $1.1b (FY, 2025) |
Net income | Net income (CHF49.2m) (FY, 2025) | Net income $14b (FY, 2025) | Net income $7.8b (FY, 2025) | Net income $435.1m (FY, 2025) | Net income ($2.8b) (FY, 2025) |
Operating ⚠ | |||||
Phase I Trials Products | Phase I Trials Products 1 (FY, 2020) | Phase I Trials Products N/A | Phase I Trials Products 51 (FY, 2024) | Phase I Trials Products N/A | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 2 (FY, 2022) | Phase II Trials Products N/A | Phase II Trials Products 27 (FY, 2024) | Phase II Trials Products N/A | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products N/A | Phase III Trials Products N/A |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products 8 (FY, 2022) | Registration Phase Products 5 (FY, 2024) | Registration Phase Products N/A | Registration Phase Products N/A |
Funding | |||||
Total funding raised | Total funding raised $ 25.9m | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised $ 100m | Total funding raised $ 1.8b |

Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View company
Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.
View company
Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
View company